Literature DB >> 22430147

Skeletal muscle abnormalities in chronic heart failure.

Panagiota Georgiadou1, Stamatis Adamopoulos.   

Abstract

Skeletal muscle abnormalities are well-established in patients with heart failure from an early stage in the progression of the disease and contribute to their symptoms and the limitation of physical activity. Heart failure-induced skeletal muscle pathology includes morphologic, histologic, and enzymatic changes along with derangements in skeletal muscle metabolism and autonomic function. These alterations influence both peripheral and ventilatory muscles, are present at rest, and deteriorate during exercise and their occurrence depends upon the severity and the duration of CHF syndrome. Future studies will be needed to elucidate the origin of skeletal "myopathy" and its reversibility, which is associated with improvement in exercise capacity, observed after physical training programs.

Entities:  

Mesh:

Year:  2012        PMID: 22430147     DOI: 10.1007/s11897-012-0090-z

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  49 in total

Review 1.  Cachexia versus sarcopenia.

Authors:  Yves Rolland; Gabor Abellan van Kan; Sophie Gillette-Guyonnet; Bruno Vellas
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-01       Impact factor: 4.294

2.  Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle.

Authors:  R Hambrecht; V Adams; S Gielen; A Linke; S Möbius-Winkler; J Yu; J Niebauer; H Jiang; E Fiehn; G Schuler
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

Review 3.  Respiratory muscle dysfunction and training in chronic heart failure.

Authors:  Eric Wong; Steve Selig; David L Hare
Journal:  Heart Lung Circ       Date:  2011-03-24       Impact factor: 2.975

4.  Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.

Authors:  Esther Latres; Ami R Amini; Ashley A Amini; Jennifer Griffiths; Francis J Martin; Yi Wei; Hsin Chieh Lin; George D Yancopoulos; David J Glass
Journal:  J Biol Chem       Date:  2004-11-17       Impact factor: 5.157

5.  31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure.

Authors:  B M Massie; M Conway; R Yonge; S Frostick; P Sleight; J Ledingham; G Radda; B Rajagopalan
Journal:  Am J Cardiol       Date:  1987-08-01       Impact factor: 2.778

6.  Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure.

Authors:  Jarrad M Scarlett; Darren D Bowe; Xinxia Zhu; Ayesha K Batra; Wilmon F Grant; Daniel L Marks
Journal:  J Endocrinol       Date:  2010-04-06       Impact factor: 4.286

7.  Physical training improves skeletal muscle metabolism in patients with chronic heart failure.

Authors:  S Adamopoulos; A J Coats; F Brunotte; L Arnolda; T Meyer; C H Thompson; J F Dunn; J Stratton; G J Kemp; G K Radda
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

8.  Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.

Authors:  Joerg Heineke; Mannix Auger-Messier; Jian Xu; Michelle Sargent; Allen York; Stephen Welle; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

Review 9.  Skeletal muscle abnormalities in chronic heart failure patients: relation to exercise capacity and therapeutic implications.

Authors:  Ilaria Nicoletti; Mariaantoinetta Cicoira; Luisa Zanolla; Lorenzo Franceschini; Giovanna Brighetti; Maria Pilati; Piero Zardini
Journal:  Congest Heart Fail       Date:  2003 May-Jun

10.  Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity.

Authors:  Elvira De Sousa; Patrick Lechêne; Dominique Fortin; Benoît N'Guessan; Souad Belmadani; Xavier Bigard; Vladimir Veksler; Renée Ventura-Clapier
Journal:  Cardiovasc Res       Date:  2002-11       Impact factor: 10.787

View more
  18 in total

Review 1.  Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction.

Authors:  D Walter Wray; Markus Amann; Russell S Richardson
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 2.  Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction.

Authors:  Bharathi Upadhya; Mark J Haykowsky; Joel Eggebeen; Dalane W Kitzman
Journal:  Curr Heart Fail Rep       Date:  2015-06

Review 3.  Osteoporosis in chronic inflammatory disease: the role of malnutrition.

Authors:  Tiziana Montalcini; Stefano Romeo; Yvelise Ferro; Valeria Migliaccio; Carmine Gazzaruso; Arturo Pujia
Journal:  Endocrine       Date:  2012-10-09       Impact factor: 3.633

Review 4.  Prevalence and importance of comorbidities in patients with heart failure.

Authors:  Filippos K Triposkiadis; John Skoularigis
Journal:  Curr Heart Fail Rep       Date:  2012-12

Review 5.  Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future.

Authors:  Eiran Z Gorodeski; Parag Goyal; Scott L Hummel; Ashok Krishnaswami; Sarah J Goodlin; Linda L Hart; Daniel E Forman; Nanette K Wenger; James N Kirkpatrick; Karen P Alexander
Journal:  J Am Coll Cardiol       Date:  2018-05-01       Impact factor: 24.094

6.  Through thick and thin: a circulating growth factor inhibits age-related cardiac hypertrophy.

Authors:  Alexandra C McPherron
Journal:  Circ Res       Date:  2013-08-16       Impact factor: 17.367

7.  Research on cachexia, sarcopenia and skeletal muscle in cardiology.

Authors:  Andrew J S Coats
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-11-16       Impact factor: 12.910

Review 8.  Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem.

Authors:  Bharathi Upadhya; Mark J Haykowsky; Joel Eggebeen; Dalane W Kitzman
Journal:  J Geriatr Cardiol       Date:  2015-05       Impact factor: 3.327

9.  Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines.

Authors:  Yae Matsuo; Konstanze Gleitsmann; Norman Mangner; Sarah Werner; Tina Fischer; T Scott Bowen; Angela Kricke; Yasuharu Matsumoto; Masahiko Kurabayashi; Gerhard Schuler; Axel Linke; Volker Adams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-03-31       Impact factor: 12.910

10.  Relationships of pulmonary oxygen uptake kinetics with skeletal muscle fatigue resistance and peak oxygen uptake in healthy young adults.

Authors:  Yusuke Kubo; Yuusuke Nishida
Journal:  J Phys Ther Sci       Date:  2013-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.